SCHOTT PHARMA AG & Co.KGaA

SCHOTT PHARMA AG & Co.KGaA

About

About SCHOTT Pharma

SCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world – because human health matters. The portfolio comprises drug containment and delivery solutions for injectable drugs ranging from prefillable glass and polymer syringes to cartridges, vials, and ampoules.

Every day, a team of around 4,700 people from over 65 nations works at SCHOTT Pharma to contribute to global healthcare.
The company is represented in all main pharmaceutical hubs with 16 manufacturing sites in Europe, North and South America, and Asia. With over 1,000 patents and technologies developed in-house, a state-of-the-art R&D center in Switzerland, and around 130 employees in R&D, the company is focused on developing innovations for the future.

SCHOTT Pharma AG & Co. KGaA, headquartered in Mainz, Germany, is part of SCHOTT AG that is owned by the Carl Zeiss Foundation. In light of this spirit, SCHOTT Pharma is committed to sustainable development for society and the environment and has the strategic goal of becoming climate-neutral by 2030.

Products

adaptiQ®

adaptiQ®

The highly standardized secondary packaging. With adaptiQ®, SCHOTT Pharma provides gold standard borosilicate vials in

Read more »
cartriQ®

cartriQ®

High-precision cartridges dedicated to performance. As a part of the SCHOTT iQ® Platform, cartriQ® is

Read more »

News

Job offers

Contact this exhibitor

Scroll to Top